2020
DOI: 10.1016/j.bios.2020.112157
|View full text |Cite
|
Sign up to set email alerts
|

Cardiac troponin I photoelectrochemical sensor: {Mo368} as electrode donor for Bi2S3 and Au co-sensitized FeOOH composite

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
9
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(10 citation statements)
references
References 49 publications
1
9
0
Order By: Relevance
“…Various molecular biomarkers for AMI have been established, including creatine kinase-MB, myoglobin, cardiac troponin T (cTnT), and cardiac troponin I (cTnI) . Clinical medical assay demonstrated that once a cardiac injury occurs, the level of cTnI in the human blood rises rapidly within 3–4 h. , Thus, cTnI has been accepted as a “golden-standard” biomarker for the diagnosis of AMI by the European Society of Cardiology, the American College of Cardiology, and the Chinese Society of Laboratory Medicine . Therefore, the development of rapid, accurate, and sensitive POCT for cTnI is of considerable importance in the diagnosis in the early development, prognosis, and monitoring of AMI. , Compared to traditional analytical methods such as liquid chromatography/mass spectrometry, chemiluminescent enzyme immunoassay, and radioimmunoassay applications, label-free electrochemical immunosensors are regarded as a promising analytical method owing to the advantages of rapidness, high sensitivity, and low cost.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Various molecular biomarkers for AMI have been established, including creatine kinase-MB, myoglobin, cardiac troponin T (cTnT), and cardiac troponin I (cTnI) . Clinical medical assay demonstrated that once a cardiac injury occurs, the level of cTnI in the human blood rises rapidly within 3–4 h. , Thus, cTnI has been accepted as a “golden-standard” biomarker for the diagnosis of AMI by the European Society of Cardiology, the American College of Cardiology, and the Chinese Society of Laboratory Medicine . Therefore, the development of rapid, accurate, and sensitive POCT for cTnI is of considerable importance in the diagnosis in the early development, prognosis, and monitoring of AMI. , Compared to traditional analytical methods such as liquid chromatography/mass spectrometry, chemiluminescent enzyme immunoassay, and radioimmunoassay applications, label-free electrochemical immunosensors are regarded as a promising analytical method owing to the advantages of rapidness, high sensitivity, and low cost.…”
Section: Introductionmentioning
confidence: 99%
“…Various molecular biomarkers for AMI have been established, including creatine kinase-MB, 20 myoglobin, 21 cardiac troponin T (cTnT), 22 and cardiac troponin I (cTnI). 23 Clinical medical assay demonstrated that once a cardiac injury occurs, the level of cTnI in the human blood rises rapidly within 3−4 h. 24,25 Thus, cTnI has been accepted as a "golden-standard" biomarker for the diagnosis of AMI by the European Society of Cardiology, 26 the American College of Cardiology, 27 and the Chinese Society of Laboratory Medicine. 28 Therefore, the development of rapid, accurate, and sensitive POCT for cTnI is of considerable importance in the diagnosis in the early development, prognosis, and monitoring of AMI.…”
Section: Introductionmentioning
confidence: 99%
“…Compared with other sensing systems referred by Jia et al (2020 ), the PMO 12 -MoS 2 / β -FeOOH@Au modified electrode (as listed in Table 4 ) had superior sensing performance toward miRNA-21 with an incredible detection limit of 0.11 fM, a broad linear range from 1 fM to 5 nM, high selectivity, good stability (15 days), excellent reproducibility, and acceptable feasibility. Bao et al (2020a ) also reported a photoelectrochemical sensor based on the matrix FeOOH/Bi 2 S 3 /AuNPs and using the hedgehog-shape{Mo 368 } cluster as an electron donor for the ultrasensitive detection of cardiac troponin I (cTnI). Combined {Mo 368 }/FeOOH/Bi 2 S 3 /AuNPs with the specific recognition of antigen and antibody, a novel sensor based on a modified ITO, and listed in Table 4 as {Mo 368 }/FeOOH/Bi 2 S 3 /AuNPs@ITO, was constructed, showing a wide detection range of 1.00 pg ml −1 –100 ng ml −1 and a low detection limit (0.76 pg ml −1 ).…”
Section: Polyoxometalates Functionalized Sensorsmentioning
confidence: 99%
“…There are also composite materials by using other materials as the substrate including Au–Pd/MnO 2 , FeOOH/Bi 2 S 3 /Au, and so on. …”
Section: States Of Art On Clinically Oriented Biosensors For Troponin...mentioning
confidence: 99%